 An initial subset of 10 subjects will be limited to patients with mild to moderate ulcerative colitis i.e., PUCAI 65 and to individuals 12 years of age. If FMT appears to be safe in this subset of patients after 8 weeks in the study to be assessed by a Data Safety Monitoring Board, expanded enrollment as is described above will occur. 